Furthermore, using synergistic analysis for two of the most significant checkpoints, CTLA-4 and PD-L1, we found that in COAD (but not in READ) tumors, both individual and simultaneous high levels of CTLA-4 and PD-L1 had a positive effect on the patients’ overall survival. The gene discussed is CTLA4; the disease is colon adenocarcinoma.